Search results for “Mitochondria targeted antioxidant” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 150 patents, we discovered top 16 key players by total patent application. Antipodean Pharmaceuticals, Inc., ORIDIS Biomed Forschungs & Entwicklungs GmbH, Stealth BioTherapeutics, Inc. are dominant in this area. They take 44.00% of the total patent filing.
Antipodean Pharmaceuticals, Inc.
California, United States
Patent: 36
ORIDIS Biomed Forschungs & Entwicklungs GmbH
Steiermark, Austria
Patent: 8
Stealth BioTherapeutics, Inc.
Massachusetts, United States
Patent: 7
Mitotech SA
Luxembourg, Luxembourg
Patent: 5
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 4
Natreon, Inc.
New Jersey, United States
Patent: 4
Roche Diagnostics Operations, Inc.
Indiana, United States
Patent: 3
Givaudan SA
Genève, Switzerland
Patent: 2
Roche Diagnostics GmbH
Germany
Patent: 2
Mitoimmune Therapeutics, Inc.
South Korea
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing Stealth BioTherapeutics, Inc., University of Florida, Cornell University take 32.14% of patent filing during this period.
Stealth BioTherapeutics, Inc.
Massachusetts, United States
Patent: 3
University of Florida
United States
Patent: 3
Cornell University
New York, United States
Patent: 3
Givaudan SA
Genève, Switzerland
Patent: 2
Regents of the University of California
California, United States
Patent: 2
Mitoimmune Therapeutics, Inc.
South Korea
Patent: 2
Centre National De La Recherche Scientif
France
Patent: 2
The Schepens Eye Research Institute, Inc.
Massachusetts, United States
Patent: 1
Université de Montpellier
France
Patent: 1
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents in last 5 years, we discover 10 new entrants. Mitoimmune Therapeutics, Inc., Givaudan SA, Centre National De La Recherche Scientif are the most active new entrants in this area.
Mitoimmune Therapeutics, Inc.
South Korea
Patent: 2
Givaudan SA
Genève, Switzerland
Patent: 2
Centre National De La Recherche Scientif
France
Patent: 2
Regents of the University of California
California, United States
Patent: 2
Gateshamppe (Wuhan) Plant Application Research Co., Ltd.
Hubei Sheng, China
Patent: 1
Wenzhou Medical College
Zhejiang Sheng, China
Patent: 1
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
Université de Montpellier
France
Patent: 1
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 1
Avignon Universite
France
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 50 patents, we discovered top 8 universities and scientific research institutions by total patent application. University of Florida, Cornell University, University of Otago are dominant in this area. They take 84.00% of the total patent filing.
University of Florida
United States
Patent: 16
Cornell University
New York, United States
Patent: 14
University of Otago
Otago, New Zealand
Patent: 12
University of Rochester
New York, United States
Patent: 6
University of Bristol
BRISTOL, United Kingdom
Patent: 1
Wenzhou Medical College
Zhejiang Sheng, China
Patent: 1
Université de Montpellier
France
Patent: 1
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: